AI News (08/13) : Anthropic plans a historic $2 trillion IPO as OpenAI hits a $40 billion revenue run rate.

The artificial intelligence landscape is witnessing an unprecedented financial and computational surge. Massive IPO plans, soaring revenue run rates, and exponential hardware expansions are rewriting the rules of tech valuation and infrastructure. From multi-trillion-dollar market ambitions to hyper-fast models and breakthroughs in clinical medicine, AI's momentum shows no signs of slowing down.

Anthropic Eyes Historic $2 Trillion IPO

The Financial Times reports that Anthropic is discussing an October IPO at a projected $2 trillion valuation—potentially eclipsing SpaceX as the largest public offering ever. Investors estimate the AI safety lab's annual revenue run rate will hit $100 billion to $120 billion by the end of 2026. While the valuation is not yet formally fixed, the news has energized retail and institutional investors alike. Why it matters: A $2 trillion IPO would cement generative AI as the primary driver of global market growth, fundamentally shifting the tech industry's financial hierarchy.

OpenAI’s Revenue Run Rate Tops $40 Billion

OpenAI’s annualized revenue run rate has surged past $40 billion as the company prepares for its own highly anticipated initial public offering. This milestone underscores the massive enterprise and consumer demand driving OpenAI's product suite forward. Why it matters: Rapid revenue growth proves that generative AI has transitioned from a speculative bubble into a highly lucrative, scaling business model.

xAI Targets Massive 10-Gigawatt Compute Expansion

Elon Musk announced plans to scale xAI’s data center capacity sevenfold to 10 gigawatts by late 2027. Musk claims this expansion, powered primarily by Nvidia’s next-generation Rubin architecture, could yield between $300 billion and $500 billion in annual revenue. Why it matters: The race for compute is escalating to utility-scale proportions, where raw electrical power directly dictates an AI company’s revenue potential.

Databricks Settles on $5 Billion Round at $190 Billion Valuation

Faced with overwhelming investor demand of up to $15 billion, Databricks secured a $5 billion funding round at a $190 billion valuation. Led by Coatue, the round supports Databricks’ expensive AI research and multi-billion-dollar cloud commitments, backed by a strong $7 billion revenue run rate. Why it matters: Even cash-flow-positive enterprise giants need massive capital infusions to cover the astronomical R&D and compute costs required to stay competitive.

OpenAI Debuts 'Ultrafast' Mode for GPT-5.6 Sol

OpenAI has launched a preview of "Ultrafast" mode for its GPT-5.6 Sol model. Powered by Cerebras hardware, the mode delivers output at 14x standard processing speed, generating up to 750 tokens per second for real-time customer support, market analysis, and incident response. Why it matters: Sub-second latency at scale unlocks complex, real-time agentic workflows that were previously bottlenecked by processing speeds.

Google Unveils Proactive AI in Pixel 11

Google is making its most aggressive hardware push yet with the Pixel 11, integrating proactive Gemini tools, live translation, and advanced AI camera capabilities directly into its flagship smartphone line. Why it matters: Consumer tech is shifting from reactive software assistants to proactive, on-device AI agents seamlessly integrated into daily life.

AI Model Predicts Biomarkers Across 32 Cancer Types

Researchers publishing in The American Journal of Pathology have created an AI model that analyzes routine histopathology images to simultaneously predict cancer subtypes, genetic mutations, and survival outcomes across 32 solid cancer types. Why it matters: Computational pathology is bridging the gap between standard clinical imaging and precise molecular oncology, enabling faster, personalized cancer diagnostics.

Antibody-Specific AI Model Accelerates Drug Discovery

Boston University researchers developed an AI framework focused solely on the binding regions of antibodies. The targeted model improved predictions of binding affinity by up to 27 percent while using significantly fewer computational resources than generic protein models. Why it matters: Tailoring AI architectures to specific biological mechanisms rather than relying on brute-force scale makes drug discovery both faster and more cost-effective.

AI Targets the Growing Fatty Liver Disease Epidemic

With fatty liver disease affecting 30 percent of adults worldwide, specialists are deploying AI tools to scan electronic health records. By flagging high-risk patients early, AI allows clinicians to intervene before irreversible liver failure or cirrhosis occurs. Why it matters: Proactive health screening via AI can prevent chronic disease progression at scale, shifting healthcare from late-stage crisis management to early prevention.

To stay up to date on everything going on in AI, check out the tracker at the500feed.com

---

Sources

1. Anthropic reportedly plans a $2 trillion IPO in October—the largest ever—that will eclipse SpaceX
2. OpenAI’s Revenue Run Rate Tops $40 Billion Ahead of IPO
3. Elon Musk says xAI will increase data center capacity 7x by 2027 — targeting 10 gigawatts of compute, up to $500 billion in revenue by the end of next year
4. Novel AI model accurately detects key gene mutations and predicts biomarkers across 32 cancer types
5. China’s Capital Flight Is Fueling Global AI. Beijing Cracks Down.
6. Databricks wanted to raise $1B, investors wanted $15B. It settled on $5B at a $190B valuation.
7. Pixel 11 AI Features: Google’s Biggest Gemini Push Yet
8. OpenAI introduces ‘Ultrafast,’ a new mode that makes GPT-5.6 Sol work at 14x the speed
9. Teaching AI the biology of antibodies speeds drug discovery
10. There’s a Fatty Liver Epidemic. AI Could Help Get Ahead of It